Role of Reactive Oxygen Species in the Progression of Type 2 Diabetes and Atherosclerosis

Mediators of Inflammation - Tập 2010 - Trang 1-11 - 2010
Hideaki Kaneto1, Naoto Katakami1, Munehide Matsuhisa1, Taka‐aki Matsuoka1
1Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan

Tóm tắt

Type 2 diabetes is the most prevalent and serious metabolic disease all over the world, and its hallmarks are pancreatic -cell dysfunction and insulin resistance. Under diabetic conditions, chronic hyperglycemia and subsequent augmentation of reactive oxygen species (ROS) deteriorate -cell function and increase insulin resistance which leads to the aggravation of type 2 diabetes. In addition, chronic hyperglycemia and ROS are also involved in the development of atherosclerosis which is often observed under diabetic conditions. Taken together, it is likely that ROS play an important role in the development of type 2 diabetes and atherosclerosis.

Từ khóa


Tài liệu tham khảo

10.2337/diabetes.48.1.1

10.1016/S0140-6736(96)90013-6

10.1016/0014-5793(88)80066-8

2001, Nature, 414, 813, 10.1038/414813a

10.1016/S0002-9149(02)03144-2

1994, American Journal of Physiology, 266, H2568

2001, Diabetes, 50, S154, 10.2337/diabetes.50.2007.S154

10.1172/JCI29103

1996, The Journal of Clinical Investigation, 97, 1041, 10.1172/JCI118496

10.1210/en.143.2.339

1995, Molecular Endocrinology, 9, 1468

1997, The Journal of Clinical Investigation, 99, 534, 10.1172/JCI119190

2003, Diabetes, 52, 1, 10.2337/diabetes.52.1.1

10.1016/S0168-8227(02)00005-0

10.1074/jbc.M410345200

1999, Diabetes, 48, 927, 10.2337/diabetes.48.4.927

10.1007/s001250051313

10.1074/jbc.274.39.27905

1999, Diabetes, 48, 2398, 10.2337/diabetes.48.12.2398

10.1074/jbc.M104115200

10.1007/s00109-005-0640-x

1997, The Journal of Clinical Investigation, 99, 144, 10.1172/JCI119126

10.2337/diabetes.52.3.581

10.1074/jbc.R400019200

1999, Proceedings of the National Academy of Sciences of the United States of America, 96, 10857, 10.1073/pnas.96.19.10857

2002, Proceedings of the National Academy of Sciences of the United States of America, 99, 12363, 10.1073/pnas.192445199

10.1016/S0006-291X(02)02832-2

1996, Biochemical Journal, 320, 855, 10.1042/bj3200855

1993, EMBO Journal, 12, 4251, 10.1002/j.1460-2075.1993.tb06109.x

10.1210/me.7.10.1275

1994, EMBO Journal, 13, 1145, 10.1002/j.1460-2075.1994.tb06363.x

10.1038/371606a0

10.1038/ng0197-106

1998, Genes and Development, 12, 1763, 10.1101/gad.12.12.1763

10.1038/75050

10.1073/pnas.192255099

2003, Diabetes, 52, 1732, 10.2337/diabetes.52.7.1732

10.2337/diabetes.53.4.1030

10.2337/diabetes.54.4.1009

10.2174/092986707781058887

2008, Endocrine Journal, 55, 235, 10.1507/endocrj.K07E-041

10.1073/pnas.102168499

10.1074/jbc.M206796200

10.1128/MCB.23.17.6049-6062.2003

10.1073/pnas.0306233101

10.1074/jbc.M412013200

10.1210/me.2007-0028

10.1016/0891-5849(96)02051-5

1997, Diabetes, 46, 1733, 10.2337/diab.46.11.1733

10.1016/j.bbrc.2006.04.011

10.1016/j.bbrc.2005.05.065

1999, Endocrinology, 140, 3422, 10.1210/endo.140.8.6908

10.1074/jbc.M409189200

2004, Diabetes, 53, 129, 10.2337/diabetes.53.1.129

10.2337/db07-0075

10.1677/JOE-07-0174

10.1172/JCI119534

1995, Diabetes, 44, 733, 10.2337/diab.44.7.733

2002, The Journal of Biological Chemistry, 277, 30010, 10.1074/jbc.M202066200

10.2337/diabetes.52.12.2896

10.1038/40194

10.1016/S0092-8674(04)00452-0

10.1038/ng890

10.1073/pnas.96.13.7421

10.1172/JCI200216857

10.1074/jbc.M508510200

2006, Cell, 125, 987, 10.1016/j.cell.2006.03.046

10.1074/jbc.273.4.1843

10.1126/science.277.5326.693

10.1038/73523

2000, The Journal of Clinical Investigation, 106, 171, 10.1172/JCI10583

10.1038/414799a

2000, The Journal of Clinical Investigation, 106, 459, 10.1172/JCI10830

2000, The Journal of Clinical Investigation, 106, 473, 10.1172/JCI10842

10.1210/er.2001-0039

10.2337/diabetes.47.10.1562

10.1074/jbc.274.15.10595

2003, American Journal of Physiology, 285, E744

10.1016/S0891-5849(99)00089-1

10.2337/diacare.22.2.280

10.2337/diabetes.54.suppl_2.S73

10.1172/JCI200525102

10.1038/nature01137

10.1074/jbc.M406963200

10.1074/jbc.275.12.9047

10.1016/S0092-8674(00)81843-7

1988, Cell, 55, 1189, 10.1016/0092-8674(88)90263-2

10.1038/4042

10.1038/nm994

10.1038/81359

10.1126/science.285.5433.1569

2001, Diabetes, 50, 77, 10.2337/diabetes.50.1.77

10.1038/nm1111

10.1126/science.287.5453.664

10.1126/science.1103160

10.1172/JCI200525102

10.1126/science.1061620

10.1038/nm1166

10.1038/nm1185

10.1007/s00125-006-0467-1

1992, Diabetes Care, 15, 1290, 10.2337/diacare.15.10.1290

1994, Diabetes, 43, 634, 10.2337/diab.43.5.634

10.1007/s001250050323

1997, Diabetes, 46, 2102, 10.2337/diab.46.12.2102

10.2337/diacare.26.2.458

2006, Diabetes Care, 29, 2445, 10.2337/dc06-0871

10.1007/s00125-004-1547-8

10.1016/j.diabres.2004.07.012

10.1161/01.STR.0000236632.58323.cd

10.1074/jbc.271.38.23317

2001, Circulation Research, 88, E14, 10.1161/01.RES.88.2.e14

10.2337/diabetes.49.11.1939

10.1161/01.CIR.0000012748.58444.08

2002, Diabetes, 51, 522, 10.2337/diabetes.51.2.522

10.1172/JCI200111927

10.1161/01.ATV.0000037101.40667.62

2006, Diabetes, 55, 209, 10.2337/diabetes.55.01.06.db05-0751

2009, Biochemical and Biophysical Research Communications, 379, 861, 10.1016/j.bbrc.2008.12.154

10.1016/j.atherosclerosis.2009.04.030

2009, Diabetes Care, 32

2000, Circulation Research, 87, 840, 10.1161/01.RES.87.10.840

10.1016/j.biocel.2005.12.008

10.2337/diabetes.47.6.945

10.1161/01.ATV.0000150649.39934.13

10.1016/S0008-6363(96)00179-4

10.1016/S0140-6736(96)90866-1

10.1056/NEJM199708073370601

10.1074/jbc.275.16.11706

1997, Arteriosclerosis, Thrombosis, and Vascular Biology, 17, 2808, 10.1161/01.ATV.17.11.2808

1998, Circulation, 97, 1731, 10.1161/01.CIR.97.17.1731

1998, Circulation Research, 82, 713, 10.1161/01.RES.82.6.713

2001, Circulation Research, 88, 1120, 10.1161/hh1101.091267

10.1126/science.1101909

10.1038/nm1335

10.1074/jbc.M409140200

10.1172/JCI26273